Drawing for Serial No. 98033548

USPTO serial 98033548

Serial No. 98033548

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CLAYTON, CHERYL A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 98033548?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janet Garetto

JANET GARETTO NIXON PEABODY LLP70 WEST MADISON STREET, SUITE 5200CHICAGO, IL 60602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Syringes sold filled with antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Intravenous bags sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Vials sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medication reservoirs and cassettes sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time which are sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnessesACTIVE—
009Downloadable electronic publications, namely, brochures, magazines and newsletters in the field of training and/or continuing education for compounding pharmacistsACTIVE—
035Pharmacy outsourcing services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Central fill pharmacy servicesACTIVE—
039Packaging and repackaging of pharmaceutical products for human use to the order and specification of othersACTIVE—
041Providing a blog website featuring non-downloadable publications in the nature of brochures, magazines, newsletters and articles regarding training and/or continuing education for compounding pharmacists in the fields of pharmaceuticals and/or pharmaceutical compounding; Non-downloadable electronic publications in the nature of brochures, magazines and newsletters in the field of training and/or continuation education for compounding pharmacistsACTIVE—
042Development of pharmaceutical preparations and medicinesACTIVE—
044Pharmaceutical compounding servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 3, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 26, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 26, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 26, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 26, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 25, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 11, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 12, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 28, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2024DOCKASSIGNED TO EXAMINER—
Jul 13, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 12, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance